The Maria Skłodowska-Curie National Oncology Institute in Warsaw started cooperation with the American National Cancer Institute (NCI), the aim of which is to develop high-quality research on the prevention, diagnosis and treatment of neoplastic diseases.
The agreement, signed on February 23 this year, will cover six main areas. The first is cancer prevention. In this area, the two institutions will continue their collaboration to date on tobacco research and HPV vaccination, and on reducing the impact of the COVID-19 pandemic on cancer care.
The second area is cancer control strategies, which will include projects related to the fight against this type of disease in Poland and the United States.
As part of another area, that is, the development of research in oncology, the cooperation will be carried out on basic, preclinical and clinical research on a global scale.
The area of data management will include the development of joint databases for the assessment of diagnosis and treatment of cancer patients. They will allow, among others on obtaining data from clinical practice.
The part devoted to new technologies in the prevention and combating of cancer will include research on various technologies for use in the fight against cancer, in particular telemedicine, artificial intelligence and robotics.
Another area will concern education and training. According to the deal, the School of Cancer Epidemiology will be established, which will be led by Polish and US lecturers - the leaders in the field of epidemiology and research methodology.
The National Cancer Institute (NCI) is the federal government's leading agency for cancer research and education. In turn, the Maria Skłodowska-Curie National Oncology Institute is currently the largest oncology facility in Poland. Its mission is to create standards in oncology, implement the National Cancer Strategy, develop innovation, as well as prevent, diagnose, treat and educate.